Legal & General Group Plc - FIVE PRIME THERAPEUTICS INC ownership

FIVE PRIME THERAPEUTICS INC's ticker is FPRX and the CUSIP is 33830X104. A total of 129 filers reported holding FIVE PRIME THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 8.29 and the average weighting 0.5%.

Quarter-by-quarter ownership
Legal & General Group Plc ownership history of FIVE PRIME THERAPEUTICS INC
ValueSharesWeighting
Q1 2021$100,000
+7.5%
2,646
-51.8%
0.00%
Q4 2020$93,000
+287.5%
5,492
+5.4%
0.00%
Q3 2020$24,000
-36.8%
5,211
-18.2%
0.00%
Q2 2020$38,000
+153.3%
6,367
-9.1%
0.00%
Q1 2020$15,000
-59.5%
7,001
-13.9%
0.00%
Q4 2019$37,000
-11.9%
8,131
-25.0%
0.00%
Q3 2019$42,000
-12.5%
10,844
+35.6%
0.00%
Q2 2019$48,000
-86.1%
7,998
-68.9%
0.00%
Q1 2019$345,000
+202.6%
25,748
+110.4%
0.00%
Q4 2018$114,000
-33.3%
12,2380.0%0.00%
Q3 2018$171,000
-7.6%
12,238
+4.8%
0.00%
Q2 2018$185,000
-15.5%
11,676
-8.6%
0.00%
Q1 2018$219,000
-26.5%
12,768
-5.8%
0.00%
Q4 2017$298,000
-28.4%
13,558
+31.9%
0.00%
Q3 2017$416,000
+44.4%
10,281
+8.7%
0.00%
Q2 2017$288,000
-13.0%
9,455
+3.1%
0.00%
Q1 2017$331,000
-0.3%
9,168
+39.2%
0.00%
Q4 2016$332,000
+71.1%
6,585
+75.5%
0.00%
Q3 2016$194,000
+14.8%
3,752
-8.0%
0.00%
Q2 2016$169,000
+5.6%
4,077
+5.4%
0.00%
Q1 2016$160,000
+16.8%
3,869
+15.8%
0.00%
Q4 2015$137,000
+168.6%
3,3420.0%0.00%
Q3 2015$51,000
-37.0%
3,3420.0%0.00%
Q2 2015$81,000
+2.5%
3,3420.0%0.00%
Q1 2015$79,000
-12.2%
3,3420.0%0.00%
Q4 2014$90,000
+125.0%
3,3420.0%0.00%
Q3 2014$40,0003,3420.00%
Other shareholders
FIVE PRIME THERAPEUTICS INC shareholders Q4 2015
NameSharesValueWeighting ↓
Eventide Asset Management 1,085,200$44,873,0002.75%
BOGLE INVESTMENT MANAGEMENT L P /DE/ 328,329$13,576,0000.94%
HAYS ADVISORY LLC 135,722$5,612,0000.87%
AWM Investment Company, Inc. 90,000$3,721,0000.80%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 448,000$18,525,0000.73%
SPHERA FUNDS MANAGEMENT LTD. 60,000$2,481,0000.64%
RTW INVESTMENTS, LP 44,701$1,848,0000.63%
Telemetry Investments, L.L.C. 26,000$1,075,0000.58%
Spark Investment Management LLC 148,100$6,123,0000.57%
Perceptive Advisors 169,439$7,006,0000.49%
View complete list of FIVE PRIME THERAPEUTICS INC shareholders